{"name":"Shenzhen SiBiono GeneTech Co.,Ltd","slug":"shenzhen-sibiono-genetech-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":5,"colorKey":"oncology","drugs":[{"name":"p53 gene therapy","genericName":"p53 gene therapy","slug":"p53-gene-therapy","indication":"Head and neck squamous cell carcinoma","status":"marketed"},{"name":"p53 gene with surgery","genericName":"p53 gene with surgery","slug":"p53-gene-with-surgery","indication":"Head and neck squamous cell carcinoma (in combination with surgery)","status":"marketed"},{"name":"rAd-p53 gene","genericName":"rAd-p53 gene","slug":"rad-p53-gene","indication":"Head and neck squamous cell carcinoma","status":"marketed"},{"name":"chemotherapy plus p53","genericName":"chemotherapy plus p53","slug":"chemotherapy-plus-p53","indication":"Head and neck cancer","status":"marketed"},{"name":"p53 with chemotherapy","genericName":"p53 with chemotherapy","slug":"p53-with-chemotherapy","indication":"Head and neck squamous cell carcinoma (in combination with chemotherapy)","status":"marketed"}]}],"pipeline":[{"name":"p53 gene therapy","genericName":"p53 gene therapy","slug":"p53-gene-therapy","phase":"marketed","mechanism":"This gene therapy delivers functional p53 tumor suppressor gene into cancer cells to restore apoptosis and cell cycle arrest.","indications":["Head and neck squamous cell carcinoma","Lung cancer"],"catalyst":""},{"name":"p53 gene with surgery","genericName":"p53 gene with surgery","slug":"p53-gene-with-surgery","phase":"marketed","mechanism":"A p53 gene therapy that restores wild-type p53 tumor suppressor function in cancer cells, typically administered intratumorally in combination with surgical resection.","indications":["Head and neck squamous cell carcinoma (in combination with surgery)","Other solid tumors with p53 mutations (off-label use in some regions)"],"catalyst":""},{"name":"rAd-p53 gene","genericName":"rAd-p53 gene","slug":"rad-p53-gene","phase":"marketed","mechanism":"rAd-p53 is a recombinant adenovirus carrying the wild-type p53 tumor suppressor gene that restores p53 function in cancer cells to induce apoptosis and inhibit tumor growth.","indications":["Head and neck squamous cell carcinoma","Lung cancer"],"catalyst":""},{"name":"chemotherapy plus p53","genericName":"chemotherapy plus p53","slug":"chemotherapy-plus-p53","phase":"marketed","mechanism":"This combination therapy uses chemotherapy alongside a p53 gene therapy to restore tumor suppressor function and enhance cancer cell death.","indications":["Head and neck cancer","Lung cancer","Other solid tumors with p53 deficiency"],"catalyst":""},{"name":"p53 with chemotherapy","genericName":"p53 with chemotherapy","slug":"p53-with-chemotherapy","phase":"marketed","mechanism":"A gene therapy that delivers functional p53 tumor suppressor gene to cancer cells to restore apoptosis and cell cycle arrest, used in combination with chemotherapy.","indications":["Head and neck squamous cell carcinoma (in combination with chemotherapy)","Various solid tumors with p53 deficiency or mutation (in combination with chemotherapy)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMisgJBVV95cUxPWGNET0pndlFaLTdxWGFKN3VzUmtVZVg1MDI5R3h2WVpWd2d1UFRjY3NfOEdjbkVETmozZnBfY3AyN0RtLThXTXhzekFVT3ppbXpDSWxQYkJ4REMxRnRmWmF0cEd2RGo0SjlFMGxDREVUbS1uMG5CSHItdzlhaUc4ZEtKdUV5RHJNQmJiSEtwWHFEVng2bVRGM3NZY0dBUWZndG1LUHEwNUMwaHVoTnBaNnJYaHJrbjVwbVhad1lqNjdCMFA0T0FyMjVIVFhUVEtLZElDVTNCWTVVdzBRY3EzUmRqYUY4Sk1CTk1OejlXZzZYVHU4Q1c1dWU4dVB4cXFoYjhpMnZPZVZmMTNFYjJITHVKMUd2WWxTUUZ5ZEk4T05LOXZPMFZtelZTVkVCX0VHR1E?oc=5","date":"2025-10-15","type":"pipeline","source":"GlobeNewswire","summary":"Global Smart Medical Devices Market Poised to Expand at a - GlobeNewswire","headline":"Global Smart Medical Devices Market Poised to Expand at a","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxNY0d0aXRxTml6akY2M01FS3dLMTlxNVNEZE1uS0ljUUJ6Y2JabzdkU3M5cEVJaXBYWnlmLWl4cWUyd08wRDB5MnBtdUI4V2hCSmtLeE5mM3BCRzJqYll1dG15VUhOUkJRQXRKTWlXc05fVFMzRGUtdXRwanNmd1JHQi0ySzdpVDBuM1pMcDZR?oc=5","date":"2022-09-14","type":"pipeline","source":"Straits Research","summary":"Viral Vector Plasmid DNA Manufacturing Market Size, Share & Trends | Industry Report, 2033 - Straits Research","headline":"Viral Vector Plasmid DNA Manufacturing Market Size, Share & Trends | Industry Report, 2033","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZ0FVX3lxTE1WcE0tdVB3RHM5RE9EZS0xRV9ZYWZab011YzZ0ZGVla0YtQ0pLYS1XbTlqNUhIZ2UyLUVSYzJqQnhPWWJGaXR3UmZOaHN5QjJUTlFNbUZabzRQdEp2eTB6VExwVzY3LXc?oc=5","date":"2017-08-08","type":"earnings","source":"Allied Market Research","summary":"Gene Therapy Market Size, Trends | Revenue Forecast- 2030 - Allied Market Research","headline":"Gene Therapy Market Size, Trends | Revenue Forecast- 2030","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxNOTl6U1BFbTFVYlF2ZGU5dmZtWmJ4dkhuRncwMFlFU3VGZTBVNDJrYlYwVTlVczlEUkVjWUl2aW1zOTJwWlExbGI4NEZTdFR4WTBod3N0Sk12ZUdDaEdiQUxwanlSWUhMUFhxRFRRTE16TlNGWUg1N1NuNFRDR2t4NVdkNEltbHQ0NmdjMDM3dS12SmhaQWtLLQ?oc=5","date":"2015-05-12","type":"pipeline","source":"Clinical Leader","summary":"Keeping Tabs On Gene Therapy? Big Pharma Is Closing In - Clinical Leader","headline":"Keeping Tabs On Gene Therapy? Big Pharma Is Closing In","sentiment":"neutral"}],"patents":[],"drugCount":5,"phaseCounts":{"marketed":5},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}